tiprankstipranks
Trending News
More News >
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market

Summit Therapeutics (SMMT) Cash flow

Compare
1,834 Followers

Summit Therapeutics Cash Flow

SMMT's free cash flow for Q3 2025 was £-95.09M. For the 2025 fiscal year, SMMT's free cash flow was decreased by £-65.36M and operating cash flow was £-95.02M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
£ -142.11M£ -76.76M£ -41.58M£ -72.59M£ -48.11M
Investing Cash Flow
£ -205.34M£ -587.77M£ -624.00K£ -306.00K£ -421.00K
Financing Cash Flow
£ 381.23M£ 86.51M£ 620.24M£ 77.92M£ 50.55M
End Cash Position
£ 105.19M£ 71.42M£ 648.61M£ 71.79M£ 66.42M
Free Cash Flow
£ -142.25M£ -76.89M£ -42.21M£ -72.89M£ -48.53M
Currency in GBP

Summit Therapeutics Cash Flow